Paper31431
Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets.
Bechgaard H and 1 other. J Pharm Pharmacol, 1978. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. Papers, record 31431. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31431
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Digestive System | Major topic |
| Adult | |
| Delayed-Action Preparations | |
| Female | |
| Half-Life | |
| Humans | |
| Ileostomy | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39034723 | Cutting-Edge Developments and Patent Trends in Microspheres Drug Delivery: A Comprehensive Overview. | Recent Pat Nanotechnol | 2025 | https://conductscience.org/library/papers/39034723 | PubMed |
| 35893801 | Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35893801 | PubMed |
| 26832133 | Design and optimization of gastro-retentive microballoons for enhanced bioavailability of cinnarizine. | Drug Deliv Transl Res | 2016 | https://conductscience.org/library/papers/26832133 | PubMed |
| 26747332 | A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine. | Drug Deliv Transl Res | 2016 | https://conductscience.org/library/papers/26747332 | PubMed |
| 25383377 | Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting. | ScientificWorldJournal | 2014 | https://conductscience.org/library/papers/25383377 | PubMed |
| 24967594 | Characterizations of plasticized polymeric film coatings for preparing multiple-unit floating drug delivery systems (muFDDSs) with controlled-release characteristics. | PLoS One | 2014 | https://conductscience.org/library/papers/24967594 | PubMed |
| 24271583 | The effect of density on the gastric emptying of single- and multiple-unit dosage forms. | Pharm Res | 1986 | https://conductscience.org/library/papers/24271583 | PubMed |
| 22615618 | Preparation and characterization of superporous hydrogels as gastroretentive drug delivery system for rosiglitazone maleate. | Daru | 2010 | https://conductscience.org/library/papers/22615618 | PubMed |
| 18459051 | Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation. | AAPS PharmSciTech | 2008 | https://conductscience.org/library/papers/18459051 | PubMed |
| 18181540 | Formulation and development of floating capsules of celecoxib: in vitro and in vivo evaluation. | AAPS PharmSciTech | 2007 | https://conductscience.org/library/papers/18181540 | PubMed |
| 16353995 | Floating drug delivery systems: a review. | AAPS PharmSciTech | 2005 | https://conductscience.org/library/papers/16353995 | PubMed |
| 10325730 | Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis. | Arch Dis Child | 1999 | https://conductscience.org/library/papers/10325730 | PubMed |
| 8234170 | A floating controlled-release drug delivery system: in vitro-in vivo evaluation. | Pharm Res | 1993 | https://conductscience.org/library/papers/8234170 | PubMed |
| 8043223 | Novel oral drug formulations. Their potential in modulating adverse effects. | Drug Saf | 1994 | https://conductscience.org/library/papers/8043223 | PubMed |
| 7859778 | Radiopharmaceuticals and the gastrointestinal tract. | Eur J Nucl Med | 1994 | https://conductscience.org/library/papers/7859778 | PubMed |
| 7075656 | Bioavailability of indomethacin from two multiple-units controlled-release formulations. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7075656 | PubMed |
| 6374610 | Oral controlled release dosage forms. A review. | Pharm Weekbl Sci | 1984 | https://conductscience.org/library/papers/6374610 | PubMed |
| 4007033 | In vitro--in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4007033 | PubMed |
| 3525340 | Where do all the tablets go in 1986? | Gut | 1986 | https://conductscience.org/library/papers/3525340 | PubMed |
| 2293216 | Gastrointestinal transit of nondisintegrating, nonerodible oral dosage forms in pigs. | Pharm Res | 1990 | https://conductscience.org/library/papers/2293216 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31431
GET https://conductscience.org/api/papers/v1/31431/cited_by?page=2